Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences

Armando Herrera-Arellano, Edgar O. López-Villegas, Aida V. Rodríguez-Tovar, Alejandro Zamilpa, Enrique Jiménez-Ferrer, Jaime Tortoriello, M. Angeles Martínez-Rivera

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Saponin SC-2 from Solanum chrysotrichum showed antifungal activity, demonstrated in vitro, which inhibited the growth of dermatophytes, and in vivo, to be effective in the treatment against tinea pedis and pityriasis capitis. Fungistatic and fungicidal activity of saponin SC-2 on Candida albicans and other Candida species, fluconazole and ketoconazole resistaent strains was demostrated. SC-2-associated ultrastructural alterations in several Candida species were observed. An exploratory clinical, randomized, double-blind, and controlled ketoconazole study of ketoconazole was conducted with the aim of assessing the effectiveness and tolerability of an herbal medicinal product containing SC-2, on women with Vulvovaginal candidiasis (VVC). The results exhibited a percentage of therapeutic clinical effectiveness similar to that of ketoconazole (X(2), p ≥0.30), but obtained a smaller percentage of mycological effectiveness, and 100% tolerability. In conclusion, saponin SC-2 possesses fungicidale and fungistatic activity on Candida albicans and other multi resistant Candida species, causes morphological changes and fungal death, and it is an alternative therapy for the treatment of VVC.

Original languageEnglish
Pages (from-to)410-417
Number of pages8
JournalAfrican journal of traditional, complementary, and alternative medicines : AJTCAM
Volume10
Issue number3
StatePublished - 2013
Externally publishedYes

Keywords

  • Solanum chrysotrichum
  • alternative therapy
  • antifungal activity
  • saponins
  • vulvovaginal candidiasis

Fingerprint

Dive into the research topics of 'Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences'. Together they form a unique fingerprint.

Cite this